EUVIMEDEUVIMED entdecken
Systematische ÜbersichtÜbersichtsarbeit

Preclinical and Clinical Evidence on the Efficacy and Cytotoxicity of Curcumin and Curcumin Derivatives in Chronic Myeloid Leukemia: A Systematic Review

Seyed Mohammad Hosseini iD, Fatemeh Peymaninezhad iD, Fatemeh Khademi iD, Alireza Khiabani iD, Alireza Khanahmad iD, Alireza Farsinejad iD, Ali Bazi iD

Phytochemical Analysis · 2026-07 · 37 (5) · 716-745

DOI: 10.1002/pca.70074 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Phytochemical Analysis, online erschienen am 01.05.2026. Verfasst von Seyed Mohammad Hosseini und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Medical Laboratory Sciences, Faculty of Allied Medicine, Kerman University of Medical Sciences, Kerman, Iran. Hauptthemen laut MEDLINE: Curcumin, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Antineoplastic Agents, Phytogenic. Die Arbeit nennt 116 Literaturangaben. Gefördert von: Kerman University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Curcumin (CUR), an active secondary metabolite of Curcuma longa , is known for its therapeutic effects in diverse neoplastic and nonneoplastic conditions. Here, we systematically reviewed relevant literature to explore the efficacy and cytotoxicity of CUR and its derivatives in treating chronic myeloid leukemia (CML) in preclinical and clinical settings.

Methods

We followed the PRISMA guideline to conduct a systematic literature search in PubMed, Web of Science, Scopus, and Embase on March 8, 2025, using relevant keywords, including chronic myeloid leukemia, CUR, and CUR derivatives. A manual search on Google Scholar was also performed to ensure comprehensive literature coverage. Duplicates were removed, and papers were evaluated for eligibility through a two‐phase screening process. Data were then extracted and qualitatively analyzed.

Results

A total of 728 publications were identified. After removing duplicates and irrelevant literature, the abstracts of 318 papers were assessed for eligibility. Finally, 64 studies (55 retrieved via database search and nine through manual search) were analyzed. Preclinical evidence demonstrated the antiproliferative and proapoptotic effects of CUR and its derivatives, alone or in combination with traditional therapies, against CML cells and models. Also, a single clinical study supported the adjunctive therapeutic effect of CUR in combination with imatinib.

Conclusion

Preclinical evidence supports the potential role of CUR and its derivatives, adjuvant or stand‐alone therapeutic agents, for CML management. More comprehensive clinical trials are warranted to validate these findings, optimize CUR formulations and dosing strategies, and maximize their clinical benefits.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CurcuminLeukemia, Myelogenous, Chronic, BCR-ABL PositiveAntineoplastic Agents, PhytogenicHumansAnimalsApoptosis

Stichwörter der Autor:innen

complementary therapiescurcumahematologic neoplasmsphytogenic antineoplastic agentssystematic review

Substanzen

CurcuminAntineoplastic Agents, Phytogenic

Autor:innen und Institutionen

  • Department of Hematology and Medical Laboratory Sciences, Faculty of Allied Medicine, Kerman University of Medical Sciences, Kerman, Iran.
  • Student Research Committee, Kerman University of Medical Sciences, Kerman, Iran.
  • Stem Cells and Regenerative Medicine Innovation Center, Kerman University of Medical Sciences, Kerman, Iran.
  • Faculty of Allied Medical Sciences, Zabol University of Medical Sciences, Zabol, Iran.

ORCID-Profile: Seyed Mohammad Hosseini, Fatemeh Peymaninezhad, Fatemeh Khademi, Alireza Khiabani, Alireza Khanahmad, Alireza Farsinejad, Ali Bazi

Förderung

  • Kerman University of Medical Sciences

Zitieren

APA

Hosseini, S. M., Peymaninezhad, F., Khademi, F., Khiabani, A., Khanahmad, A., Farsinejad, A., & Bazi, A. (2026). Preclinical and Clinical Evidence on the Efficacy and Cytotoxicity of Curcumin and Curcumin Derivatives in Chronic Myeloid Leukemia: A Systematic Review. Phytochemical Analysis, 37(5), 716-745. https://doi.org/10.1002/pca.70074

Vancouver

Hosseini SM, Peymaninezhad F, Khademi F, Khiabani A, Khanahmad A, Farsinejad A, et al. Preclinical and Clinical Evidence on the Efficacy and Cytotoxicity of Curcumin and Curcumin Derivatives in Chronic Myeloid Leukemia: A Systematic Review. Phytochemical Analysis. 2026;37(5):716-745. doi:10.1002/pca.70074

BibTeX
@article{Hosseini2026,
  author = {Hosseini, Seyed Mohammad and Peymaninezhad, Fatemeh and Khademi, Fatemeh and Khiabani, Alireza and Khanahmad, Alireza and Farsinejad, Alireza and Bazi, Ali},
  title = {Preclinical and Clinical Evidence on the Efficacy and Cytotoxicity of Curcumin and Curcumin Derivatives in Chronic Myeloid Leukemia: A Systematic Review},
  journal = {Phytochemical Analysis},
  year = {2026},
  volume = {37},
  number = {5},
  pages = {716--745},
  doi = {10.1002/pca.70074}
}
Kostenlos starten →